Please assess the completion status of the following clinical trial:

Trial Title: Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* all consecutive PCI patients with stent implantation of our institution~Exclusion Criteria:~* pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- standard therapy (Type: ACTIVE_COMPARATOR): standard dual antiplatelet therapy after PCI for all patient populations (stable CVD and ACS)
- individualized therapy (Type: EXPERIMENTAL): dual antiplatelet therapy modified according to clopidogrel on-treatment platelet reactivity measured by Multiplate Analyzer

Based on this trial design, predict the completion outcome and termination type (if applicable).